Imaging Endpoints Establishes Operations in Shanghai

October 27, 2021 – Imaging Endpoints announced today that it has established a new office in Shanghai, China. Imaging Endpoints has strategically opened offices around the world to provide its real-time services as efficiently as possible while working more closely with clinical trial sites in more than forty countries. Shanghai, China is home to rapidly growing pharmaceutical and biotech innovations in Asia.

“Establishing operations in Shanghai is a logical next step in our global expansion. While we already provide first in class services, including real-time reads, to many clients in Asia, having a presence in Shanghai will allow us to work more closely with our rapidly-growing APAC clients,” said Doug Dean Burkett, Ph.D., Chief Executive Officer and President.

Imaging Endpoints has expanded its globality to include eight offices across six countries and three continents. Imaging Endpoints is the fastest growing, and largest oncology-focused imaging CRO (iCRO). Its impressive growth is a product of its commitment to service excellence and its position as the industry leader in radiology science, technology, and regulatory compliance.

Imaging Endpoints works with nearly all imaging sites globally that participate in clinical trials, and the expansion of operations into Shanghai will enable key team members, such as project managers and radiology experts, to work real-time with their counterparts in China and throughout the Pacific Rim.

For more information on Imaging Endpoints, visit imagingendpoints.com.